Partner Content Partner Content Preliminary Attendee List Released for Orphan Drugs & Rare D... Attendees Released for Orphan Drugs & Rare Diseases
Partner Content Partner Content How challenges like Brexit & insufficient patients hinde... Challenges facing Orphan Drugs & Rare Diseases Research
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
